Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...
Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...
GLP-1 medications have reached a level of household penetration that food and beverage brands can no longer ignore, but the impact on grocery sales is unfolding more gradually than some might expect.
The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it. Healthcare companies have been feverishly working on developing GLP-1 weight loss products in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results